Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE

Vestal Point Capital, LP reported a 5.40% stake in Monte Rosa Therapeutics, Inc. (Schedule 13G)

Event Jun 30, 2026 · Filed Aug 14, 2026

Vestal Point Capital, LP reported a 5.40% stake in Monte Rosa Therapeutics, Inc., 4,600,000 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).

Stake
5.40%
Shares
4,600,000
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Vestal Point Capital, LP5.40%4,600,000
Ryan Wilder5.40%4,600,000

Source

View original at SEC

Related